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Abstract
Background: Public health leadership in England has taken a distinctive international stance by identifying the
potential public health benefit of e-cigarettes for smoking cessation. This includes the development of a ground-
breaking set of national guidelines for developing e-cigarette friendly stop smoking services. However, little is known
about the views of staff engaged within these services and whether or how such services are becoming e-cigarette
friendly. This study aimed to investigate the uptake and usage of e-cigarette guidance, from the perspective of those
enacting tobacco cessation interventions ‘on the ground’.
Methods: Qualitative semi-structured interviews were conducted with 25 cessation service staff, including advisors
(n = 15), managers (n = 5) and commissioners (n = 5) from eight different services in the South-West of England, UK. A
thematic analysis of the transcripts was conducted using NVivo software.
Results: Although some stop smoking services labelled themselves e-cigarette friendly, there was no consensus over
what this should entail. For some, this meant active engagement, such as working with local vape shops, and in the
case of one service, offering e-cigarettes through a voucher scheme to disadvantaged groups. For others, an e-cigarette
friendly service was conceptualized in a passive sense, as one which welcomed service users using e-cigarettes. Many
services did not use the ‘e-cigarette friendly’ claim in their branding or promotional material. Several discursive themes
underlay differing staff attitudes. Those more reluctant to engage framed this in terms of their ‘duty of care’, with
concerns focusing on the addictiveness of nicotine, lack of medically licensed product and ongoing scientific
controversy. Those motivated to engage drew on a discourse of social justice goals and ‘doing things differently’
in relation to lower socio-economic status smokers, those with mental health issues and other vulnerable groups.
Strong public health leadership was also identified as a key factor in changing staff attitudes towards e-cigarettes.
Conclusions: On-the-ground enactment of e-cigarette friendly services is varied as well as reflective of the wider
policy and regulatory environment. Although the context of English stop smoking services is one of austerity and
change, there are opportunities for active engagement with e-cigarettes to achieve overall cessation goals. For this to
occur, training, policy consistency and sharing best practice are needed.
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Background
E-cigarettes deliver nicotine through vapour rather than
combustible means as with tobacco smoking.1 There is a
lack of international consensus over the public health
role for e-cigarettes [1]. Debate has focused on the rela-
tive estimates of the health benefits of vaping compared
with tobacco smoking [2, 3], the unknown long-term
risks [4–6], the role of flavours [7, 8], their use by mi-
nors/children [9], their effect on bystanders [10, 11] and
their effectiveness for tobacco cessation [12–15]. Using
e-cigarettes as a tool for smoking cessation within
health-care services is controversial. Proponents of
e-cigarette use, such as Public Health England (PHE)
and NHS Health Scotland, have suggested vaping may
have a role to play similar to existing therapeutic prod-
ucts, such as nicotine replacement therapy (NRT) vare-
nicline and buproprion [16–18]. In contrast, public
health bodies such as the World Health Organization
have been more cautious [19, 20].
Given this lack of consensus, regulatory regimes have
become divergent [21]. In countries such as Singapore,
Thailand, India and Australia there are tight regulatory re-
gimes that either ban or heavily restrict accessibility to
e-cigarettes (e.g. [10, 22]). Others, such as Canada and
New Zealand, have moved recently towards legalizing and
regulating vaping [23]. To some extent, this can be char-
acterized as an ideologically driven debate between abstin-
ence advocacy and harm reduction approaches to drug
use, with the latter favouring incorporation of e-cigarettes
into smoking cessation services [24, 25] (although see also
[26]). Divergence also reflects the paucity of conclusive
evidence alongside the lack of existing market regulation
for such products. In Europe, the Tobacco Products
Directive (TPD) of 2016 makes provision for medical li-
censing of products as part of a twin-track approach,
alongside consumer regulation. However, no such product
is currently on the market and licensed [27].
Guidance for English cessation services to become
e-cigarette friendly is ground-breaking and certainly in
opposition to some international policy positions. The
rationale for including e-cigarettes is to combine the
most popular method of quitting [28] with the most ef-
fective; behavioural support plus pharmacotherapy [29].
According to guidance produced by the National Centre
for Smoking Cessation and Training (NCSCT) in 2016,
an e-cigarette friendly stop smoking service is defined as
one who ‘supports clients who want to use an e-cigarette
to help them quit smoking and reaches out to smokers
considering using an e-cigarette to come to the service
for behavioural support’ ([30], p. 10). Advisors are rec-
ommended to familiarize themselves with e-cigarettes
(e.g. by reading forums, visiting a shop) and be positive
in their language (e.g. do not say ‘we can’t recommend
one’ which might sound condemnatory, rather say ‘we
can’t supply them, but we can certainly offer the extra
support…’) (p. 10). The guidance also suggests that ser-
vices do not challenge long-term e-cigarette use as it
may be protective against relapse (p. 10).
The NCSCT report is part of a complex picture of guid-
ance about using e-cigarettes for smoking cessation which
has emerged in the past 5 years in the UK. Public Health
England released a seminal report in 2015, updated in
2018, stating that e-cigarettes are approximately 95% safer
than tobacco cigarettes [16, 27]. Action on Smoking and
Health (ASH) (a campaigning charity influential in to-
bacco control) supported this stance with their 2014
and 2016 briefings [28, 31] as did the Royal College of
Physicians [32]. In contrast, in 2016, Public Health Wales
were considering a legislative ban on e-cigarettes in some
public places. More recently, in 2017/8, policy statements
from UK Public Health bodies have aligned in relation to
encouraging e-cigarette users to use stop smoking services
[18, 27, 33]. National Institute for Health and Care Excel-
lence (NICE)’s guidance is slightly more cautious. It rec-
ommends health professionals give information about
e-cigarettes but does not list them as evidence-based in-
terventions for stop smoking services [34]. In comparison
with international examples, the policy guidance to in-
corporate e-cigarettes into cessation services in England
and now in the wider UK is distinctively positive. Little is
known, however, about if and how staff in such services
have responded to the call to be e-cigarette friendly.
The English stop smoking services, which are free at
the point of use, are almost unique internationally. Their
long-term effectiveness has been tracked over time [35]
and the basis for their success theoretically articulated
[36, 37] and empirically evaluated [38]. However, re-
cently, there have been multiple changes to these ser-
vices. First, they have been moved from National Health
Service management to local authority control. Funding
has been cut by 50% [39] and 25% of local authorities no
longer commission specialist stop smoking services [39].
Second, there has been a transition towards integrating
smoking cessation into other ‘lifestyle’ or ‘wellbeing’ ser-
vices [40]. Third, there has been a focused targeting of
vulnerable/‘hard to reach’ smokers (e.g. who are lower
socio-economic status, have mental health issues and/or
co-occurring addictions, also pregnant women) to close
the health inequalities gap [41]. These groups can be
harder to attract, retain and treat successfully within
services [42]. Finally, there has been an overall de-
cline in use of cessation services. The introduction of
e-cigarettes is understood by staff to be a key reason for
the drop in footfall [43]. Thus, the decision to consider
e-cigarette use as part of cessation services may not only
be ideological but pragmatic: ignoring e-cigarettes could
render stretched services obsolete. Other staff may fear
e-cigarettes are hastening their decline.
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International research has begun to delineate health
professionals’ perspectives on e-cigarettes. For example, a
recent study of doctors and tobacco counsellors in the
Netherlands found that although a majority saw vaping as
less risky than tobacco smoking, they did not see it as an
effective cessation aid and did not strongly recommended
it to their own patients [44]. Research from the US on
professional attitudes has found them predominantly
negative toward e-cigarettes due to lack of evidential cer-
tainty, leading GPs [45] and quit line professionals [46] to
reject recommending them. However, there are signs that
this dominant negative response may be changing. Recent
research with US patients who were smokers found that
over half of their personal physicians had spoken to them
about e-cigarettes as potential quit aids [47]. Similarly, a
qualitative study of US physician experiences with
e-cigarettes found that although physicians were ambiva-
lent about recommending e-cigarettes due to uncertainty
over long-term effects and safety, they were not averse to
doing so, particularly if new/more positive evidence be-
came available [48]. A US study of junior doctors found
that those who recommended vaping therapeutically were
more likely to hold a harm reduction model of treatment
rather than an abstinence one [49]. Overall then, a hetero-
geneous picture is emerging, where negative attitudes are
the norm, but also where shifts over time, and shifts in
thinking by health care professionals are also occurring.
In England, Hiscock and colleagues have tracked
changes in stop smoking service staff attitudes since
2011 through a series of surveys. Practitioners reported
both greater interest in and use of vaping amongst cli-
ents at later time points [43, 50]. Practitioners them-
selves have also become positive about e-cigarettes over
time, with 15% agreeing or strongly agreeing ‘e-ciga-
rettes are a good thing’ in 2011, to 26% in 2013, and
24.4% in 2014. Of course, this still indicates that the
large majority of staff do not see e-cigarettes as a good
thing. Furthermore, differences emerged between pro-
fessional roles, with those with a more policy-oriented
role, such as managers and commissioners, being more
positive about e-cigarettes than those working directly
with smokers [43]. In line with the international re-
search, practitioners were concerned about the addic-
tiveness of e-cigarettes, and their safety/effectiveness, as
well as the lack of licensed product [50, 51]. One quali-
tative study, which examined both stop smoking user
and advisor attitudes, found that uncertainty was foun-
dational to ambivalent attitudes towards e-cigarettes
[52]. From the perspective of clients using cessation
services, the safety of e-cigarettes is their primary con-
cern [53, 54]. Furthermore, some clients have reported
other people’s long-term use of nicotine via e-cigarettes
could be potentially threatening to their own nicotine
abstinence goals [55].
Innovative practice is emerging. One pilot funded ini-
tiative in London has incorporated e-cigarettes as part of
its cessation treatment [56]. They found clients to be
positive about their use, with particular success when
combining e-cigarettes with varenicline [56]. Other stop
smoking services, such as Leicester City, Bristol City and
Hampshire (Quit 4 Life), have reported trialling the
provision of e-cigarettes or vouchers to clients, but no
research is currently published.
The existing research on stop smoking staff attitudes
was conducted prior to the publication of the Public
Health England report (2015) and the NCSCT guidance
(2016). This study therefore investigates how these
macro-level national policy interventions have or have
not shifted attitudes and practices with cessation ser-
vices in what is a fast-moving context. Studying staff be-
liefs and experiences in relation to e-cigarette friendly
services is important for several reasons. First, it offers
an opportunity to ascertain how policies or training
guidance are being interpreted in practice. Lipsky has ar-
gued that front-line staff are the site of policy enactment
in public service, and it is their ‘discretionary’ application
of top-down edicts that determines whether or not
changes occur in day-to-day practice [57]. Second, it al-
lows the qualitative exploration of both ideological and
practical challenges that e-cigarettes might pose within
professional practice. Staff are schooled within a medical
model of smoking cessation including pharmaceutical
treatment for nicotine dependence [58]. E-cigarettes are
a consumer-led technology which has originated outside
the medical sphere [59]. This may create problems for
service integration.
This study sought to investigate these issues through a
qualitative exploration of how cessation staff experience the
challenge to be e-cigarette friendly within their services,
given wider national and international policy contexts.
Method
Design, sample and procedure
The data reported here was drawn from a larger qualita-
tive study investigating stop smoking services responses
to e-cigarettes, including observational and interview
data with staff, clients and users of vape shops. A pur-
posive sampling strategy was used [60], aiming to ensure
a spread of experience and staff roles. Qualitative
semi-structured interviews were conducted with 25 ces-
sation services/tobacco control staff, in the following
broad categories: advisors (n = 15), managers (n = 5) and
commissioners (n = 5), although two ‘commissioners’
also had managerial roles in services because the supply/
commissioning division had been abolished. Advisors
saw clients on a daily basis delivering cessation interven-
tions face-to-face and by telephone, also running
groups/outreach in the community (e.g. with pregnant
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women, with local addiction groups). Managers/leads
had a role in overseeing cessation advisors and commu-
nity staff (e.g. pharmacists) and in devising local tobacco
control strategy in line with their contracts and national
policy. Commissioners were responsible for issuing to-
bacco control contracts alongside other public health
spheres as well as devising/overseeing policy initiatives.
Initial recruitment was conducted through the Public
Health England (PHE) Tobacco Control network in the
South-West which is a local network organized by PHE
to disseminate policy and share best practice, involving
all tobacco managers/commissioners in the region. The
first author gave a short presentation about the project
at a quarterly meeting. Managers/commissioners who
expressed interest at this meeting were then approached
formally by email with written information. Managers
further disseminated the invitation to participate to their
advisors. This author also visited two services to explain
what participation would involve to the whole team. Out
of 11 services in the South-West network, 8 had at least
one member of staff participate, ensuring a spread of
services were represented.
Interviews were conducted primarily at the service
workplace, face-to-face, in separate rooms for privacy rea-
sons (n = 21). Some phone interviews of managers/commis-
sioners were also conducted (n= 4). Recruitment was
stopped when saturation of experience/themes was reached.
Data was collected from December 2016 to March
2018. The data collection timespan was relatively long
because services were undergoing restructuring/change
during this period.
The relevant NHS and university ethics committee ap-
proved the study. Participants signed and returned an infor-
mation/consent sheet, retaining one copy for themselves,
consenting to the recording, transcription and use of their
interview for academic purposes. In the text, participants
(indicated by P below) are anonymized and denoted by
their role (e.g. advisor, manager, commissioner). Because of
the changes to services, and their divergent structures, job
titles were often very distinct (e.g. health improvement offi-
cer, lifestyle advisor). These were altered in the text to en-
sure anonymity and to make their role clear.
Measures
Interviews were semi-structured in format, based on an
interview schedule [60]. Initial wide-ranging pilot inter-
views with one manager and one advisor were con-
ducted and the final schedule developed from these.
Interview questions covered (a) the person’s job role; (b)
the structure of services and recent changes; (c) whether
services used the phrase ‘e-cigarette friendly’ and if so
what this meant, including any interaction with vapers/
vape shops; (d) personal experiences and opinions on
e-cigarettes within services; (e) policy and media issues
with e-cigarettes (e.g. changes in risk perceptions, scien-
tific evidence, media stories) and (f ) how they saw the
future unfolding in relation to e-cigarettes.
Analysis
Transcripts were coded using NVivo software, using
Braun and Clarke’s method [61]. There are two stages to
this (a) initial descriptive content codes are generated
then and (b) these are drawn together in ‘higher order’
analytic themes to produce an interpretation. This is
both a top down and bottom up process. Themes were
generated from the material itself (e.g. on recent changes
to services) as well as from previous reading/literature
(e.g. health professionals’ uncertainty about the scientific
evidence). The first draft of the analysis was generated
by the first author and reviewed/reworked by the second
until interpretation was agreed.
Results
The findings are structured into three major themes:
theme one concerns the activities and attitudes of services
in relation to becoming e-cigarette friendly, including their
underlying values; theme two locates staff-identified bar-
riers to integrating e-cigarettes into services, and; theme
three analyses the role of public health leadership and
guidance in driving e-cigarette friendly services.
Theme one: active and passive approaches to being
e-cigarette friendly
The changing context of stop smoking services
The interviews revealed that staff were working in the
context of considerable change, both in their own roles
and in the wider structures of local public health: ‘we’ve
been through a lot of change’ (P49, manager). Many staff
now had a remit to work on lifestyle change in the wider
sense, including weight loss, not just tobacco control. Job
titles were also changing to reflect this, such as ‘wellbeing
practitioner’ or ‘health improvement advisor’. There was
also a renewed emphasis on targeting ‘hard to reach’ or
‘disadvantaged’ smokers with the most intensive behav-
ioural support (e.g. face-to-face counselling):
There’s pockets of deprivation across the city, quite
extreme health inequalities, and so we target, we run
our clinics in key deprived neighbourhoods…we do
some work with the mental health community
outreach teams…although [those smokers] are
incredibly difficult to engage with (P49, manager)
In some services, this was coupled with a withdrawal
of services from clients deemed to require less interven-
tion (e.g. offering them online or telephone services).
Most services had also seen cuts to staff numbers or to
health promotion provision. The need to consider
Farrimond and Abraham Harm Reduction Journal  (2018) 15:38 Page 4 of 12
e-cigarettes as part of treatment protocols was therefore
part of a wider context of change within stop smoking
services:
We know that we were not seeing the numbers…and
that’s when e-cigs came in, we were already having
less people coming through (P46, advisor)
Viewing e-cigarettes more positively within cessation ser-
vices was described variously by staff as a ‘shift’, ‘turnaround’
or ‘change’ and more negatively as a ‘trend’ or ‘fad’.
Passive approaches
All the stop smoking services in this sample were
e-cigarette friendly in a passive sense. This was character-
ized by a tolerance of e-cigarette use by clients using their
own private vaporizers/e-cigarettes within the service:
We do say our service is e-cigarette friendly so
if somebody wanted to quit smoking using the
e-cigarettes, we would welcome them into the service.
Obviously, we won’t recommend any particular
e-cigarette for them but we would provide the
behavioural support for them to quit smoking
(P38, commissioner)
No service reported turning away e-cigarette users or
expressing disapproval of using vaping as a method of
quitting. To this extent, they all fulfilled the broad defin-
ition of an e-cigarette friendly service, by accepting vap-
ing as a personal choice of quit aid. This in itself was a
recent shift for many. One service contacted about par-
ticipating in early 2016 had initially declared ‘oh no, we
don’t have anything to do with them (e cigarettes)’.
However, by the time staff were interviewed almost
6 months later, they had all had training and were open
to e-cigarette use as a matter of service policy. For some
services, it had been written into their contract or ‘offer’,
re-characterizing e-cigarette friendliness as a deliverable
measurable target, rather than just an aspirational state-
ment of intent. Managers and commissioners in particu-
lar, were vocal about their openness to vaping: ‘I
cascaded that report (PHE) to all of Public Health… it’s
really important that advisors are aware that…people
can be supported to vape’ (P18, manager). This manager
also acknowledged that ‘the confidence of the advisors’
was holding back the service from being truly e-cigarette
friendly which they were addressing through training.
However, despite welcoming vapers who presented at
the service, many services did not use the phrase
‘e-cigarette friendly’ or ‘vape friendly’ on their branding
or promotional materials, such as on Twitter, in leaflets
or websites. There was also concern about appearing
‘too e-cigarette friendly’. For example, one commissioner
had dropped a proposal to invite e-cigarette shops to a
launch event primarily because of nervousness from
others in the public health team about being ‘too sort of
wedded to the e-cigarette shops for want of a better way
of explaining that’ (P38) as the others in the team were
‘terrified of collusion with the industry’.
Active approaches
A smaller number of services were more actively en-
gaged in promoting e-cigarettes within their offer to ser-
vice users. Their justification for doing so can broadly be
described as motivated by social justice goals, to engage
the ‘hard to reach’ groups experiencing health inequality:
‘we know that we have to do something different….-
We’ve got areas of the city where smoking rates are at
about 30-35% and…those people, they’re not engaging
with what we’re currently offering’ (P36, manager).
The need to ‘do things differently’ was particularly
pressing in relation to provision for those with mental
health difficulties. Many mental health/psychiatric wards
were going ‘smoke-free’, having previously been exempt
from public bans on smoking. For example, one
city-based service did not use any e-cigarette friendly
branding, but was considering e-cigarette provision for
users with mental health needs:
We’re just currently coming to the end of running
some focus groups for in-patients and staff around
us going smoke free and how we can best support
them…and e-cigarettes is the thing that’s just
screaming out (P49, manager)
Only one cessation service we interviewed was cur-
rently offering e-cigarettes to service users. In 2016, this
service started an e-cigarette voucher scheme in five lo-
cations including community groups (e.g. healthy living
centres and voluntary organizations) in disadvantaged
areas to attract unemployed, manual workers and other
groups with high smoking rates. A clinic was also lo-
cated within local Drug and Alcohol services to attract
people engaged in substance misuse treatment. Clients
were offered a combination of NRT/varenicline and an
e-cigarette voucher with behavioral support, alongside
other types of social provision. As one of the commis-
sioning managers explained ‘the beauty of this offer in a
community group is that they’re not just offering a pre-
scription or a voucher, but they’re also linking the offer
to the community assets that they have at hand…it
might be debt management or counselling or housing…’
(P36). Working with local vaping shops was critical to
the operationalization of the scheme which did not spe-
cify which product clients should use but allowed them
to choose, up to the value of the voucher. Advisors
noted the positive experience of working with the vape
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shops: ‘I think they’re just really, really professional and
really caring and really genuinely want to help people
quit smoking alongside me’ (P51, advisor).
Although other services were not offering e-cigarettes as
an official part of their service, some had formed tentative
relationships with vape shops in their area. For example,
in one service, they had invited the manager of a chain of
local vape stores to their staff meetings 2 years in a row to
update them on vaping technology. This initiative was al-
most universally described positively by staff. Another ser-
vice had designed a ‘Code of Conduct’ for e-cigarette
shops. Another manager had tried something similar in
their area and found ‘they were keen to sign up to it’; how-
ever, there were tensions over rules concerning never sell-
ing to non-smokers, as vape shop owners saw potential
exemptions as justifiable (e.g. for drug harm reduction or
for weight loss) (P38, commissioner). There was uncer-
tainty, however, about what the relationship between ces-
sation services and local vape shops could and should
look like. Although overtures had been made, and many
staff had visited vape shops on fact-finding visits, there
were few formalized alliances or plans for longer-term
interaction at this time-point, apart from the one
e-cigarette voucher scheme.
Theme two: barriers to e-cigarette integration
Practical barriers
Many of the barriers to using e-cigarettes within services
were pragmatic ones, which were the consequence of the
structure and economics of service provision, rather than
any ideological resistance. Currently, e-cigarettes are not
available on prescription within the NHS. Advisors were
able to used prescription routes for NRT but not for
e-cigarettes. Advisors, who were in touch with the every-
day reality of clients’ lives, were pragmatic about the
choices they were making: ‘they are people for whom
change is really difficult, often they are living… in abject
poverty…e-cigarettes are often a way forward but they’re
too expensive… whereas nicotine replacement is on pre-
scription and cheap’ (P14, advisor).
Many staff felt that offering e-cigarettes on prescription
would be the ideal way to incorporate vaping into stop
smoking services, giving it equivalence with their licensed
products. However, one or two advisors were adamantly
against them being on prescription: ‘no, absolutely not.
They want them, they buy them…why should the NHS
now start supporting their habit?’ (P13, advisor).
Concerns about habit and long-term use
Some staff reported they had ongoing concerns about in-
corporating e-cigarettes into their practice. They reported
their clients had tried them and ‘they don’t get on with
them’ (P11, advisor) or ‘they don’t deliver what they want’
(P14, advisor). A key issue was whether vaping broke the
‘habit’ of smoking, amid concerns it might continue their
dependence: ‘it’s very easy to go back to smoking because
they haven’t really broken that habit…people can vape
where they couldn’t smoke before so I think they’re in-
creasing their use’ (P11, advisor).
Some advisors were particularly concerned about the
long-term use of e-cigarettes. This led them to prefer
time-limited schemes similar to NRT: ‘I’d be happy to in
the same way as we do nicotine replacement therapy and
things like that’ (P12, advisor). Others saw the benefit of
long-term use but were still concerned about entrenching
habitual behaviour: ‘I think it’s not so much the chemical
danger, it’s the behavioural danger…the door is never
closed on the habit. There’s always that possibility of going
back to old behaviours’ (P15, advisor).
In connection with long-term use, perhaps unexpectedly,
a few advisors reported vapers approach the service about
quitting vaping: ‘I have also had people coming into my
clinic asking to go onto some nicotine replacement
programme to come off e-cigarettes’ (P13, advisor). At least
a couple of advisors were actively engaged in helping people
quit vaping. This was a surprise to their manager who was
emphatic they did not offer a ‘stop vaping’ service.
Concerns about negative health effects, safety and lack of
licensed products
A few advisors were concerned about potential negative
health effects of vaping: ‘e-cigarettes can cause
arrhythmia and…if you quit smoking, and [have] high
quantities of unregulated nicotine in an e-cigarette, it
can actually cause unaccountable symptoms for a patient
and that can be quite dangerous for them’ (P14, advisor).
Two out of the 25 staff mentioned ‘popcorn lung’ as a
genuine concern rather than in the context of media
stories: ‘research has shown that…popcorn lung…is
making a difference’ (P17, advisor).
More commonly, however, there were ongoing con-
cerns about the lack of evidence relating to safety: ‘I have
to explain to our patients that they are unregulated and
that we cannot vouch for their safety, that there is no
one product that could be used on prescription’, (P14,
advisor). The lack of a prescribed or a medically ‘en-
dorsed’ product also made many advisors nervous about
suggesting them: ‘it would give me more certainty. To
be put on prescription the drugs have to be inspected…
passed by NICE guidelines…that would instil a bit of
faith in me that what I was saying was right’ (P17, ad-
visor). One commissioner explained the conflict of their
advisors: ‘they’re not against them just for the sake of it,
but they also have this duty of care and that makes them
feel uncomfortable when they’re recommending prod-
ucts that are not either within NICE guidelines or are
not medically regulated’ (P18). That said, staff were
mostly aware that a medically licensed product was not
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likely in the foreseeable future and many argued a stan-
dardized prescribed e-cigarette would not necessarily de-
sirable: ‘it wouldn’t really work, because they are all so
diverse’ (P14, advisor).
Staff also felt relatively powerless at times in the face
of ‘scare stories’ within the media:
I mean, we have got a thing on the window on our
door now saying that Public Health England say they
are 95% safer, and the amount of people who have no
idea, they have never heard that. You know, as soon
as somebody’s e-cigarette explodes, it’s in the Sun,
it’s in the Mail, it’s in the Mirror’ (P39, manager)
Many felt that media scare stories were driving public
attitudes towards vaping more than public health.
Tension over the profit/private nature of e-cigarettes supplies
A final source of concern for all staff was that public
health is fundamentally a public enterprise. Engaging
with a consumer product from the private sector was
therefore problematic. One commissioner summed up
the problem: ‘they’ve got profit in mind and we’ve got
health in mind, and does that go together?’ (P37). An-
other commissioner found that their colleagues in public
health were concerned: ‘we shouldn’t necessarily endorse
any particular e-cigarette provider or any e-cigarette. I
think it’s just a risk averse thing’ (P38). Even more chal-
lenging was the ‘ethical dilemma’ of potentially engaging
with tobacco companies: ‘we just couldn’t get somebody
turning up that, you know, from British American
Tobacco or something, saying ‘oh we’ve got this vape
product, but holistically, I guess you’ve got to think that
people do want to stop smoking whatever the product,
but it’s a difficult one. We’ll have to cross that bridge I
guess’ (P18, manager). This fear of industry collusion,
and of the profit motive of vape shops, was given as an
explanation to account for not engaging more actively.
Theme three: the role of public health leadership
Resistance from wider public health
Despite national policy changes, at a local level, there
was often resistance to e-cigarettes from wider local
public health. As one commissioner stated ‘I spend more
time trying to convince my colleagues than doing any-
thing else’ (P36). This often constrained local practice,
for example, one service manager had tried to convince
the HR (human resources) department of the council
which employed them to separate their smoke-free pol-
icies on vaping and smoking in line with PHE guidance
and had failed. As she stated ‘in our council policy they
class vaping the same as they do smoking, despite myself
and our Director of Public Health having a meeting with
our HR colleague and Health and Safety to explain that
actually you know, vaping could be allowed in the work-
place, they chose not to’ (P37).
Influential figures and reports/guidance
Strong national public health leadership gave staff the
confidence to challenge negative views about
e-cigarettes. Particular figures and organizations within
public health were mentioned throughout the interviews
as the source of changing attitudes, such as key aca-
demics researching e-cigarettes, for example, ‘Robert
West’ and ‘Linda Bauld’, advocacy organizations such as
the ‘New Nicotine Alliance’ and other services, most
notably ‘Leicester Stop Smoking Service’ which was the
first e-cigarette friendly service in England:
I came back from the London one, PHE conference
on e-cigarettes and you know, Peter Hajek again, he
was talking, so right, that’s it, I’m going to present this
to the [management board responsible for Tobacco]
now…and so I’ve tried to present this very scientific
evidence…I think it did start to break down some
barriers… (P37, manager)
In terms of organizations, a large number of staff men-
tioned ‘Public Health England’ (PHE) as a key influence
in giving them the confidence to engage positively
around e-cigarettes:
So, as a service I’d say comparatively we were
cautious to perhaps some other areas that were a little
bit more, I am going to say ‘gung ho’….and then as
you know Public Health England have come out and
endorsed them and really been quite pro-them, and
more evidence has come out then, so obviously we,
on the back of that, we have been a lot more
e-cigarette friendly (P49, manager)
In particular, the PHE report of 2015, containing the
statistic that e-cigarettes were estimated to be 95% less
harmful than combustible cigarettes, was mentioned nu-
merous times as a key turning-point in attitude change.
The report gave staff a sense of greater certainty and au-
thority, allowing themselves to reassure others about the
utility of vaping as a cessation tool: E-cigs are 95% less
harmful. We are constantly saying that…to midwives for
example, who are a bit reluctant to encourage people to
use e-cigs (P36, advisor).
Fundamentally, participants reported, clear leadership
had changed attitudes:
Originally there were [tricky conversations] because
there was no clear cut what we were meant to say… it
was the taboo thing you couldn’t talk about…but I
now feel with all the information that’s coming out
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from the NCSCT about the smoking forum, the
smoking pregnancy forum, it’s a lot clearer
(P12, advisor)
That said, not everyone was convinced by the public
health shift towards e-cigarettes. One advisor, when asked
about the PHE report stated: ‘inwardly, I go no. People
keep turning up at the clinics saying oh they’re safe, can
you give me one…I think we need a longer period of time
before we can say that, the long-term effects of
them.’(P11, advisor). Another argued that public health
had moved too quickly on this topic: ‘I just think they’re
probably too hasty’ (P13, advisor). Others were aware that
past guidance and attitudes were still influencing them:
It’s having to change our thinking, is not it? I am still
in that state, you know, initially it was thought of as
‘the enemy’…’We do not recommend, we do not
recommend’, I mean it’s very strong and suddenly we
are saying, actually it’s ok, you know, so that’s very
odd (P14, advisor)
Discussion
Lipsky has argued that polices become practice in public
service through the application of on the ground ‘discre-
tion’ [57]. So smoking cessation services become
e-cigarette friendly not only through endorsing such a
policy in service descriptions, mission statements and
contracts, though these are important, but through
wholescale changes in practice by advisors. This occurs
through what sociology terms ‘micro-social interactions’
with clients, by literally ‘being friendly’ to users of ser-
vices with e-cigarettes at various points of contact that
occur daily, whether on the phone, online or
face-to-face. To a large extent, staff within the services
sampled in this study were e-cigarette friendly in this
sense. This was most notable at the managerial level [43]
but many advisors were also engaged, the majority hav-
ing taken part in at least one training session on
e-cigarettes. In comparison with the more negative atti-
tudes shown by health professionals in the Netherlands
and USA [44, 46], the English cessation services staff in
this sample were more positive about being open to
working with e-cigarette users, suggesting that transi-
tions in attitudes are occurring. However, there were
limits to this positivity. There was still some use of hesi-
tant language around ‘not being able to recommend’
e-cigarettes which the NCSCT’s guidelines suggest may
be interpreted negatively by clients. Furthermore, even
though all services allowed e-cigarette users to access
behavioural support, most did not identify themselves in
their branding and promotional literature as e-cigarette
friendly. This raises the question of how potential clients
would know services welcomed e-cigarettes if it was not
explicitly stated. A few services were more proactive in
‘reaching out’ to vapers, for example, meeting with local
vape shops or, in the case of one service offering an
e-cigarette voucher for a starter kit to clinic attendees in
disadvantaged areas. We conclude that there is no con-
sensus on what constitutes an e-cigarette friendly service
and that further guidelines on the specifics are needed.
Nonetheless, a fundamental shift towards seeing its im-
portance has occurred.
Additionally, this research has identified a number of
important discursive themes framing service responses
to vaping. One concerns the ‘morality’ or ‘ethics’ of in-
corporating e-cigarettes into cessation services. Both
staff who were cautious and those who were enthusiastic
drew on ethical and value discourses to explain their po-
sitions. The ongoing lack of a licensed e-cigarette prod-
uct for prescription concerned many staff, in line with
previous research [51]; this was framed here in terms of
a ‘duty of care’ towards clients. There was also wide-
spread concern about the profit motive, mirroring wider
conflicts in international public health over the role of
industry in driving vaping [62]. Staff more actively en-
gaged with e-cigarette users justified their actions by
drawing on ethical discourses relating to social justice
and ‘care for the vulnerable’, particularly in relation to
treating disadvantaged smokers or those with mental
health issues. They argued ‘we have to do something dif-
ferent’ given the intractable nature of entrenched smok-
ing in these groups. The battle between those who are
broadly pro and anti-vaping has been characterized as
one between harm reduction and prohibition [63]. This
is not necessarily the case in England, where prohib-
itionist rhetoric is scarcer, and in which the mantra of
‘patient choice’ is more pronounced. It was notable that
even the more reluctant advisors in this study did not
think banning or prohibiting vaping was the way for-
ward. Their concern was not the private use of vaping
by the individual; it was about whether e-cigarettes fitted
within an evidence-based, licensed and publically funded
treatment programme. These concerns are not surpris-
ing, given staff are schooled in a medical model of smok-
ing cessation treatment. We concur with Hajek that in
public health ‘ideology and morality can play at least as
big a role as evidence and logic’ (p. 1).
The second discursive theme identified was the im-
portance of public health leadership and guidance. A
document of key importance for this sample was the re-
port released in 2015 by Public Health England that esti-
mated vaping to be approximately 95% safer than
tobacco smoking. Numerous staff stated that it was this
statistic in particular that gave them ‘reassurance’ and
‘confidence’ to reverse their previous reluctance to en-
gage and more openly welcome e-cigarette users into
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the service. This suggests that, in an ongoing climate of
differing international responses, media scare stories and
scientific uncertainty, public health leadership and guid-
ance is able to perform a legitimating role for health
professionals. This does not mean that many staff did
not continue to have concerns, but rather that their ac-
tive disengagement was reversed to an acceptance of
vaping, stamped with medical authority.
There are, nonetheless, implementation issues that need
to be addressed. One important contextual problem is that
English stop smoking services are fragmented and consti-
tuted differently in different regions. Public Health Eng-
land and the NCSCT have a primarily advisory role.
Fundamentally, tobacco leads and managers are answer-
able to their local council boards and commissioners, who
issue (or do not renew) their contracts and include (or do
not include) targets relating to e-cigarettes. Our findings
suggest an ongoing nervousness in wider public health
and beyond about the use of e-cigarettes, evidenced by the
difficulty several services reported in enacting change
around working with vape shops and having separate
smoking/vaping policies within council offices. As one
commissioner explained, if your own council is not fol-
lowing clear Public Health England guidance on separat-
ing smoking and vaping for employers, your overall
credibility is affected. Although many managers and com-
missioners in this sample were working hard to change at-
titudes, until this wider lack of confidence and knowledge
is addressed, other public health and council colleagues
(e.g. in HR) may present a significant barrier to establish-
ing truly e-cigarette friendly services.
That said, innovative practice was occurring. In the vou-
cher scheme example, local vape shops were chosen to re-
ceive vouchers (a redeemable method of payment from
the council) so that the local population could access the
intervention without having to travel. Such
community-embedded initiatives may circumvent the dis-
like of the medicalization of e-cigarettes by some users
[64] and a fear of judgment and moralization of health be-
haviours by health professionals [65]. It is arguable that
for smoking cessation work to succeed, it is going to have
to move beyond specialist clinics which few smokers at-
tend and engage with vulnerable populations in their com-
munities. Initiatives to support smoking cessation could
occur in psychiatric units, community mental health set-
tings, in addiction clinics, in community centres and
smoke-free hospitals. E-cigarettes have the potential to be
part of ‘doing things differently’ for marginalized and
harder to treat smokers. For example, a Royal College of
Physican’s Report in 2018 has suggested allowing vaping
within hospital grounds as a smoking cessation tool [66].
It is also important to hear negative as well as positive
voices concerning policy support for integrating
e-cigarettes. A number of advisors with day to day
experience of working with quitting smokers held nega-
tive, ambivalent or just reservations about the wholescale
move towards e-cigarettes, more so than at the managerial
level [43]. Their attitudes highlight experientially based is-
sues with e-cigarettes that may explain why, although
popular, up to 40% of current smokers do not want to try
them, and many that have do not continue with it [67].
These include disliking being addicted to nicotine, experi-
ential/unpleasant aspects of vaping (e.g. lung/throat sensa-
tion, feeling ‘suffocated’) and preferring medically licensed
products. It is not just a matter of dismissing these as
‘myths’ about e-cigarettes, and to assert that if done cor-
rectly, vaping is pleasurable and long-term use not a prob-
lem. It may be that for some clients, using existing models
of treatment such as NRT and habit-breaking [68, 69], or
vaping within a more medical model of treatment with
the option of a defined weaning off period, are their pre-
ferred treatment goals which align with their differential
needs [64]. A ‘one size fits all’ approach may not be opti-
mal for smoking cessation.
From a policy perspective, these results suggest several
pathways forward. Services were stronger on ‘welcoming’
existing e-cigarette users than ‘reaching out’ to potential
new clients as the NCSCT guidance recommends.
Services should consider communicating their
e-cigarette friendliness through branded/promotional
material. Strong public health leadership and the sharing
of successful initiatives are also important. Innovative
practice is taking place in England, such as the voucher
scheme discussed here. However, often managers/com-
missions did not know about these innovations, or if
they did, were short on the details of how exactly they
operated. Knowing how others have overcome concrete
issues with funding, convincing others in public health
and structuring interventions would be very useful.
Short reports targeting service managers (as well as
peer-reviewed publications) could help overcome this
barrier to change. Such reports could focus on pragmatic
“how-to” guidelines and provide concrete details on ser-
vice implementation which are sometimes limited in
journal articles.
There are several limitations to this study. Firstly, it is
geographically limited to the South-West region of
England. It may be that attitudes and training ap-
proaches relevant to e-cigarettes are different in the
South West Public Health England network sampled
here to other parts of England and elsewhere. As such,
the emergent e-cigarette friendliness of this sample may
not be mirrored elsewhere. Furthermore, qualitative re-
search, whilst theoretically generative, cannot be general-
ized [60]. A larger-scale national study would be
required to map similarities and differences, including
use of quantitative methods. Finally, services were in a
state of flux, meaning that the research took longer than
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expected to conduct. Those interviewed at the start of
the data collection period may have conveyed very dif-
ferent views than if they had been interviewed at the
end. The results presented here, like much work on
e-cigarettes, may date quickly as the policy context and
regulatory environment itself changes.
Conclusions
In conclusion, given the strong association between smok-
ing and disadvantage [70], cessation services in England
have an important role in preventing further health in-
equalities. Even if throughput is declining within trad-
itional stop smoking clinics, the work of smoking
cessation is continuing within communities, hospitals, ad-
diction services, psychiatric wards and in public spaces.
Cessation services that are e-cigarette friendly have the
potential to make considerable impact in terms of harm
reduction, particularly if supported through training, pol-
icy consistency and the sharing of best practice.
Endnotes
1It is possible to vape non-nicotine products as well, al-
though these form a small minority within the marketplace
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